Publisher
Springer Science and Business Media LLC
Reference61 articles.
1. Gould, S. E., Junttila, M. R. & de Sauvage, F. J. Translational value of mouse models in oncology drug development. Nat Med. 21, 431–439, doi: 10.1038/nm.3853 (2015).
2. Marques, A. & Muller, S. Mouse models of autoimmune diseases. Curr Drug Discov Technol. 6, 262–269, doi: 10.2174/157016309789869047 (2009).
3. Grosso, J. F. & Jure-Kunkel, M. N. CTLA-4 blockade in tumor models: an overview of preclinical and translational research. Cancer Immun. 13, 5 (2013).
4. Junttila, T. T. et al. Antitumor efficacy of a bispecific antibody that targets HER2 and activates T cells. Cancer Res. 74, 5561–5571, doi: 10.1158/0008-5472.CAN-13-3622-T (2014).
5. Loisel, S. et al. Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment. Crit Rev Oncol Hematol. 62, 34–42, doi: 10.1016/j.critrevonc.2006.11.010 (2007).
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献